Curaleaf Holdings (CURLF) Free Cash Flow (QoQ) (2019 - 2024)
Curaleaf Holdings (CURLF) Free Cash Flow (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -146.52% |
| Sep 30, 2024 | 100.16% |
| Jun 30, 2024 | -199.83% |
| Mar 31, 2024 | 115,494.35% |
| Dec 31, 2023 | -161.01% |
| Sep 30, 2023 | 100.79% |
| Jun 30, 2023 | -199.81% |
| Mar 31, 2023 | 3,796.75% |
| Dec 31, 2022 | -585.65% |
| Sep 30, 2022 | 219.43% |
| Jun 30, 2022 | -142.13% |
| Mar 31, 2022 | 267.86% |
| Dec 31, 2021 | -75.17% |
| Sep 30, 2021 | 406.47% |
| Jun 30, 2021 | -222.74% |
| Mar 31, 2021 | 114.35% |
| Dec 31, 2020 | -1,047.50% |
| Sep 30, 2020 | -64.20% |
| Jun 30, 2020 | 148.30% |
| Mar 31, 2020 | 112.60% |